Delaying the start of iron until 28 days after antimalarial treatment is associated with lower incidence of subsequent illness in children with malaria and iron deficiency.

Citation data:

PloS one, ISSN: 1932-6203, Vol: 12, Issue: 8, Page: e0183977

Publication Year:
2017
Usage 904
Full Text Views 888
Abstract Views 16
PMID:
28854208
DOI:
10.1371/journal.pone.0183977
Author(s):
Ericka G. Jaramillo, Ezekiel Mupere, Robert O. Opoka, James S. Hodges, Troy C. Lund, Michael K. Georgieff, Chandy C. John, Sarah E. Cusick, D William Cameron
Publisher(s):
Public Library of Science (PLoS)
Tags:
Biochemistry, Genetics and Molecular Biology, Agricultural and Biological Sciences
article description
We evaluated the incidence of all-cause and malaria-specific clinic visits during follow-up of a recent trial of iron therapy. In the main trial, Ugandan children 6-59 months with smear-confirmed malaria and iron deficiency [zinc protoporphyrin (ZPP > = 80 μmol/mol heme)] were treated for malaria and randomized to start a 27-day course of oral iron concurrently with (immediate group) or 28 days after (delayed group) antimalarial treatment. All children were followed for the same 56-day period starting at the time of antimalarial treatment (Day 0) and underwent passive and active surveillance for malaria and other morbidity for the entire follow-up period. All ill children were examined and treated by the study physician. In this secondary analysis of morbidity data from the main trial, we report that although the incidence of malaria-specific visits did not differ between the groups, children in the immediate group had a higher incidence rate ratio of all-cause sick-child visits to the clinic during the follow-up period (Incidence Rate Ratio (IRR) immediate/delayed = 1.76; 95%CI: 1.05-3.03, p = 0.033). Although these findings need to be tested in a larger trial powered for malaria-specific morbidity, these preliminary results suggest that delaying iron by 28 days in children with coexisting malaria and iron deficiency is associated with a reduced risk of subsequent all-cause illness.

This article has 0 Wikipedia mention.